Abstract
Microfluidic devices on chip-based systems are becoming increasingly popular, because of many advantages, like low mobile phase consumption and greatly reduced analysis times. The ultimate goal is to design all-including labon- a-chip tools that can be employed in the field and that integrate all elements necessary for an analysis, e.g. one or more separation channels, (multiple) detectors, mixing chambers and sample pretreatment areas. The chip format permits to make any channel pattern, rendering the applications of lab-on-a-chip unlimited. However, overcoming the limitations inherent with the detection systems remains a challenging problem. Whereas UV-detection is predominant in the larger systems, its sensitivity is inadequate due to the minute pathlengths employed in a chip. This review summarizes the shortcomings of UV detection, and discusses some possible solutions. Besides, it presents an overview of the alternative detection methods that have been employed in pharmaceutical and chiral chip analysis, including their positive and negative aspects as well. Finally, the applications reported on the chips are discussed.
Keywords: Detection, Microfluidic device, Lab-on-chip system, Pharmaceutical analysis, Chiral separation
Current Pharmaceutical Analysis
Title: Detection Systems for Microfluidic Devices with a Major Focus on Pharmaceutical and Chiral Analysis
Volume: 5 Issue: 2
Author(s): I. Tanret, D. Mangelings and Y. Vander Heyden
Affiliation:
Keywords: Detection, Microfluidic device, Lab-on-chip system, Pharmaceutical analysis, Chiral separation
Abstract: Microfluidic devices on chip-based systems are becoming increasingly popular, because of many advantages, like low mobile phase consumption and greatly reduced analysis times. The ultimate goal is to design all-including labon- a-chip tools that can be employed in the field and that integrate all elements necessary for an analysis, e.g. one or more separation channels, (multiple) detectors, mixing chambers and sample pretreatment areas. The chip format permits to make any channel pattern, rendering the applications of lab-on-a-chip unlimited. However, overcoming the limitations inherent with the detection systems remains a challenging problem. Whereas UV-detection is predominant in the larger systems, its sensitivity is inadequate due to the minute pathlengths employed in a chip. This review summarizes the shortcomings of UV detection, and discusses some possible solutions. Besides, it presents an overview of the alternative detection methods that have been employed in pharmaceutical and chiral chip analysis, including their positive and negative aspects as well. Finally, the applications reported on the chips are discussed.
Export Options
About this article
Cite this article as:
Tanret I., Mangelings D. and Heyden Vander Y., Detection Systems for Microfluidic Devices with a Major Focus on Pharmaceutical and Chiral Analysis, Current Pharmaceutical Analysis 2009; 5 (2) . https://dx.doi.org/10.2174/157341209788172951
DOI https://dx.doi.org/10.2174/157341209788172951 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Determinants of Anti-Cancer Effect of Mitochondrial Electron Transport Chain Inhibitors: Bioenergetic Profile and Metabolic Flexibility of Cancer Cells
Current Pharmaceutical Design Editorial: [Hot Topic: Primary Sjogren’s Syndrome Research and Therapy: Has a New Dawn Arrived?]
Current Pharmaceutical Biotechnology Selective Inhibitors of Hepatitis B Virus Replication
Current Medicinal Chemistry - Anti-Infective Agents Study to Know the Impact of Ayurvedic Lifestyle on Dark Circles Around Eyes
Current Traditional Medicine T11TS/SLFA-3 Differentially Regulate the Population of Microglia and Brain Infiltrating Lymphocytes to Reduce Glioma by Modulating Intrinsic Bcl-2 Expression rather than p53
Central Nervous System Agents in Medicinal Chemistry Editorial (Hot Topic:Recent Advance in the Studies of Beta-glucans for Cancer Therapy)
Anti-Cancer Agents in Medicinal Chemistry “Virostatics” as a Potential New Class of HIV Drugs
Current Pharmaceutical Design Chemoprevention of Colorectal Cancer: Progress or Pipedream?
Current Cancer Therapy Reviews Hemodynamic Forces Regulate Embryonic Stem Cell Commitment to Vascular Progenitors
Current Cardiology Reviews Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Current Gene Therapy Epidemiology, Prevention, and Management of Influenza in Patients with Hematologic Malignancy
Infectious Disorders - Drug Targets CD34+ Fibrocytes: Morphology, Histogenesis and Function
Current Stem Cell Research & Therapy Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets CRF Receptors as a Potential Target in the Development of Novel Pharmacotherapies for Depression
Current Pharmaceutical Design Neuropharmacology of Stress-Induced Mucosal Inflammation: Implications for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Current Molecular Medicine MicroRNA-155 Regulates Inflammatory Response in Ischemic Cerebral Tissues through Autophagy
Current Neurovascular Research Old and New Gasotransmitters in the Cardiovascular System: Focus on the Role of Nitric Oxide and Hydrogen Sulfide in Endothelial Cells and Cardiomyocytes
Current Pharmaceutical Biotechnology Predicting Drug Efficacy Using Integrative Models for Chronic Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Mesenchymal Stem Cells Inhibited Dendritic Cells Via the Regulation of STAT1 and STAT6 Phosphorylation in Experimental Autoimmune Uveitis
Current Molecular Medicine Synthetic Peptides in the Diagnosis of Systemic Autoimmune Diseases
Current Protein & Peptide Science